Purdue Asks Federal Circuit To Rehear OxyContin Patent Case
Purdue Pharma has asked the U.S. Court of Appeals for the Federal Circuit to review its decision last month to uphold a lower court's devastating determination that three patents for the...To view the full article, register now.
Already a subscriber? Click here to view full article